 |
-
Life Science Tool Companies: John L. Sullivan, Leerink Swann & Co.
-
Life Science Tools & Instruments: Ted Tenthoff, Piper Jaffray & Co.
-
CEO Interviews (average 2,500 words): Top management from 3 sector firms examine the outlook for their firm and the sector. Firms interviewed include: New Brunswick Scientific Co., PRA International and Solexa, Inc.
Topics covered: Research funding
- Drug discovery
- New products development
- Company competition
- Budget constraints
- M&A activity
- Genotyping markets
- FDA safety responsibilities
Companies covered: Charles River Labs (CRL), Covance (CVD), PerkinElmer (PKI), Varian, Inc. (VARI), Waters (WAT), Techne (TECH), Serologicals (SERO), Sigma-Aldrich (SIAL), drug discovery, Thermo Electron (TMO), Affymetrix (AFFX), Luminex (LMNX), Illumina (ILMN), Invitrogen (IVGN), Applied Biosystems (ABI) and deCODE genetics (DCGN).
This Issue
costs $175 - and is non-returnable.
The Wall Street Transcript
does not endorse the views of any interviewee nor does it make stock recommendations.
|
 |

Investors and Industry Execs.
The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.
TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best.
Money manager interviews provide the view from the buy-side.
CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.
Subscribe to a unique research tool for investors and industry executives. Call
(212) 952 7433 or click here.
Sincerely,
Andrew Pickup
Publisher
|
|
 |